Chief executive and vice chairman Rajeev Nannapaneni lays bare the changing face of global pharma, explaining why Indian generics firms are scouting for new opportunities.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.